Fraport, the owner and operator of Frankfurt Airport (FRA), has put to use two additional state-of-the-art refrigerated trailers for the transportation of temperature-sensitive pharmaceutical products. This will take Fraport’s total fleet for cross-apron transportation up to 20 temperature-controlled transporters.
The new dollies, called ‘cool boxes’ allow pinpoint transportation of temperature-sensitive products in a range of between -20 and +300 Celsius. Each transporter has two cabins, which can be accessed efficiently from both sides and is also fitted with an individually adjustable cooling system. Even when the engine is switched off and the outside temperature is 300 Celsius, the cabin will remain at the set temperature for over 60 minutes. The transporters also have an electronic temperature monitoring system and a tracking system, which enable them to continuously transmit up-to-the-minute loading information.
“The two new refrigerated transporters will give us maximum flexibility when it comes to handling temperature-sensitive goods. We have profound expertise in this area, and our customers benefit from this. It means that we can offer ideal infrastructure conditions together with our partners at Air Cargo Community in Frankfurt,” said Siegfried Pasler, Head of Ground Handling Services at Fraport AG.
“Last year, we handled 120,000 metric tons of pharmaceutical products at Frankfurt Airport, making us Europe’s leading pharmaceutical hub. The expansion of the fleet significantly underpins our status even further, particularly with a view to the upcoming transportation of the coronavirus vaccine,” explained Max Philipp Conrady, Head of Cargo Infrastructure and Development at Fraport AG.
Frankfurt Airport currently has around 12,000 sq mt of temperature-controlled handling capacity available for pharmaceutical products. Another 2,000 square meters are about to be put into operation.
Over 75% of the airport’s transport routes are certified in accordance with international and European CEIV1 standards.